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Fig.　1　Effect of theophylline on eosinophil adhesion to HU-
VEC stimulated by 10 pM TNF-α in the absence of (open 
column), or in the presence of 100 pM IFN-γ (black closed 
column). For each bar, the mean ± SEM of 5 experiments is 
shown. *p < 0.01, compared to control; **p < 0.0001, com-
pared to control.
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Dear Editor
Theophylline Attenuates the Adhesiveness
of Endothelial Cells Augmented with
Interferon-γ in the Presence of TNF-α
for Blood Eosinophils
Theophylline has been traditionally used to treat
asthma. It exerts anti-inflammatory effects, including
the induction of eosinophil apoptosis1 and the reduc-
tion of degranulation,2 adhesion3 and migration4 of
these cells in response to a T-helper type 2 (Th2) im-
mune reaction. This anti-inflammatory effect of theo-
phylline leads to reduced eosinophil influx to the air-
ways. However, the effect of theophylline on the func-
tions of eosinophils induced by T-helper type 1 (Th1)
cytokines remains ambiguous.
Eosinophils can serve as major effector cells in
asthma. Adhesion to vascular endothelium is an in-
itial step for eosinophils to accumulate in bronchial
tissue. Eosinophils significantly adhere to vascular
endothelium stimulated not only by Th2 cytokines,3
but also Th1 cytokines such as interferons (IFNs) in
the presence of tumour necrosis factor-α (TNF-α).5
This phenomenon partly attributed to the increase in
the expression of adhesion molecules on vascular en-
dothelial cells induced by Th2 cytokines or IFNs.3,5
The aim of the present study was to evaluate
whether theophylline modifies the adhesion of
eosinophils to human umbilical vein endothelial cells
(HUVEC) stimulated by IFNs in the presence of
TNF-α.
We performed statistical analysis as follows ; A
paired t-test for comparison of two groups and re-
peated measures ANOVA with Scheffe’s constants for
comparison between more than two groups. A p-
value, 0.05 was considered statistically significant.
Initially we confirmed IFNs augment the adhesive-
ness of vascular endothelial cells for eosinophils in
the presence of TNF-α, compared to HUVEC stimu-
lated by only TNF-α, as previously reported5 (n = 7,
data not shown). Methods were as follows; HUVEC
(Clonetics, San Diego, CA, USA) were prepared as
previously described.6 Confluent monolayers of HU-
VEC in collagen-coated 96-well tissue culture plates
were treated with IFN-γ (100-300 pM) together with
TNF-α (10 pM) and cultured in 5% CO2 at 37°C for 24
h. After that, to block the synthesis of mediators, HU-
VEC were treated as previously described before
use.5 Eosinophils were isolated from peripheral blood
from normal volunteers by the negative immunomag-
netic bead selection method as previously described.7
Eosinophils were placed onto the HUVEC monolay-
ers and then incubated at 37°C for 30 min. Eosinophil
adhesion to HUVEC was assessed as residual eosino-
phil peroxidase (EPO) activity of adherent eosino-
phils, as previously described.8
Subsequently, we determined whether theophyl-
line modulated the spontaneous adhesion of eosino-
phils to IFN-γ-stimulated HUVEC. We pre-incubated
eosinophils with theophylline (0.1-1 mM) for 30 min
at 37°C and then incubated eosinophils placed on
HUVEC stimulated by 100 pM IFN-γ in the presence
of 10 pM TNF-α, or by only TNF-α, at 37°C for 30
min. After that we treated the reaction wells as de-
scribed above and measured EPO. Theophylline (1
mM) significantly diminished the adhesion rate of
eosinophils to HUVEC activated by IFN-γ in the pres-
ence of TNF-α, as well as to HUVEC activated by only
TNF-α (Fig. 1).
We next investigated whether theophylline re-
duced the IFN-γ-promoted expression of intracellular
adhesion molecule 1 (ICAM-1) andor vascular cell
adhesion molecule 1 (VCAM-1) on HUVEC in the
presence of TNF-α, to determine the inhibitory effect
of theophylline on the adhesiveness of HUVEC stimu-
lated by IFN-γ. HUVEC were cultured with IFN-γ
(100-300 pM) in the presence or absence of TNF-α
(10 pM) for 24 h, and the expression of ICAM-1 and
VCAM-1 was measured by cell ELISA.5 As previously
reported,5 we confirmed that in the presence of TNF-
α, IFN-γ significantly up-regulated the expression of
ICAM-1 and VCAM-1 on HUVEC (n = 3, data not
shown).
Finally, we determined whether theophylline
modulated the expression of ICAM-1 and VCAM-1,
when stimulated by IFN-γ in the presence of TNF-α.
We cultured HUVEC in the presence or absence of
theophylline for 1 h and stimulated them with a com-
bination of IFN-γ (100 pM) and TNF-α (10 pM) for 24
h, and then the expression of ICAM-1 and VCAM-1
were measured by cell ELISA. Theophylline signifi-
cantly reduced the expression of not VCAM-1 but
ICAM-1 on HUVEC stimulated by IFN-γ in the pres-
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Fig.　2　(a) and (b): Effect of theophylline on the expression of ICAM-1 (a) and VCAM-1 (b) stimulated by 
TNF-α (10 pM) in the absence of (open column), or in the presence of 100 pM IFN-γ (black closed column). 
For each bar, the mean ± SEM of 4 different experiments is shown. OD, optical density.
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ence and absence of TNF-α (Fig. 2a, b).
This study showed the reduction of adhesion of
eosinophils to IFN-γ-stimulated HUVEC in the pres-
ence of TNF-α was attributable to the effect of theo-
phylline on both eosinophils and HUVEC. IFN-γ
seemed to enhance the adhesiveness of HUVEC
through promotion of the expression of ICAM-1 and
VCAM-1 on HUVEC in the presence of TNF-α.6 Inter-
action of eosinophils with VCAM-1 or ICAM-1
seemed to be involved in the enhancement of the ef-
fector functions of eosinophils, including the release
of radical oxygen species and the production of cyste-
inyl leukotriene. 5-8 The exposure of eosinophils to
these molecules can enhance their adhesiveness.
Therefore, the reduction of the adhesiveness was
partly because theophylline attenuated the expres-
sion of ICAM-1 on IFN-γ-stimulated HUVEC. This co-
incides with the attenuation of ICAM-1 and VCAM-1
on HUVEC stimulated with a combination of inter-
leukin-4 (IL-4) and TNF-α, by theophylline.3 Addition-
ally, the cyclic AMP analogue N 6, 2)-O-dibutyl-
adenosine 3)5)-cyclic monophosphate, attenuated the
expression of adhesion molecules on HUVEC stimu-
lated with a combination of IL-4 and TNF-α,3 suggest-
ing that the reduction of the expression of adhesion
molecules by theophylline resulted from the eleva-
tion of intracellular cyclic AMP levels.
Theophylline inhibits the up-regulation of β2 in-
tegrin expression on activated eosinophils through
the elevation of intracellular cyclic AMP levels. 2,3,9
Human eosinophils normally express β2 integrins.
Thus theophylline may inhibit function of β2 integrin
on eosinophils, leading to a reduction in the adhesion
to IFN-γ-stimulated HUVEC. Theophylline attenuates
the expression of L-selectin, which is also involved in
extravasation and is increased by IFN-γ.9 It may con-
tribute to the reduction of eosinophil adhesion to HU-
VEC.
Our results suggest that theophylline exerts potent
anti-inflammatory effects on bronchial inflammation
arising from the action of Th1 cytokines. Th1 cytoki-
nes contribute to bronchial inflammation in various
situations, including resistance to corticosteroids
seen in severe asthma, and viral infections leading to
asthma exacerbation. Theophylline supplements the
anti-inflammatory effects of corticosteroids in as-
thma.10 Consequently, theophylline can be a feasible
medication option, in addition to corticosteroids, es-
pecially for asthma modified by a Th1 immune re-
sponse.
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